Prostate cancer remains one of the most commonly diagnosed cancers among men in the UK. Advances in diagnostics and the availability of non-invasive treatment options, such as HIFU and NanoKnife, are helping to expand care choices for patients at various stages.
Current Approaches to Prostate Cancer Diagnosis and Treatment in the UK
Prostate cancer is among the most prevalent cancers affecting men in the UK, particularly those over the age of 50. While early stages often present no noticeable symptoms, routine testing for prostate cancer has become an essential part of men's health, particularly for those with risk factors such as family history or elevated PSA levels.
Screening and Diagnosis
The most common method of screening is the PSA blood test, which may be followed by additional imaging or a biopsy if results indicate abnormalities. Improved diagnostic tools now allow for earlier and more accurate detection, which is critical for identifying candidates for less aggressive treatment methods.
Treatment Options: From Conventional to Minimally Invasive
Traditional approaches to prostate cancer treatment—such as surgery or radiation—remain effective in many cases. However, newer minimally invasive treatments are offering patients alternatives that may involve fewer side effects and shorter recovery times.
Two such options available in select clinics across the UK are:
HIFU (High-Intensity Focused Ultrasound): A procedure that uses sound waves to precisely target and destroy cancerous tissue within the prostate. HIFU is typically considered for localised cancers and is valued for its precision and low impact on surrounding tissues.
NanoKnife treatment: A non-thermal ablation technique that uses electrical pulses to disrupt cancer cells. Though still under evaluation in many regions, it is viewed as a promising option for cases where traditional surgery may not be suitable.